pT1 SUBSTAGING IN RENAL CELL CARCINOMA: VALIDATION OF THE 2002 TNM STAGING MODIFICATION OF MALIGNANT RENAL EPITHELIAL TUMORS
Mohamed E. Salama(The University of Texas at San Antonio Health Science Center), Mariza de Peralta‐Venturina(Henry Ford Hospital), Hans Stricker(University Hospital of Bern), James O. Peabody(Henry Ford Hospital), Mitual Amin(Oakland University), Edward L. Peterson, M. Menon(Indian Institute of Technology Delhi), Khurshid A. Guru(Roswell Park Comprehensive Cancer Center)
Cited by 35
Related Papers
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
|Schizophrenia Bulletin|2009|915
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
|Cancer Cell|2017|619
Spectrum of Epithelial Neoplasms in End-Stage Renal Disease
|The American Journal of Surgical Pathology|2006|484
A genetic mechanism for Tibetan high-altitude adaptation
|Nature Genetics|2014|441